GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $822,717 | +203.4% | 18,900 | +203.6% | 0.79% | +253.1% |
Q1 2022 | $271,161 | -5.0% | 6,225 | -3.9% | 0.22% | -3.0% |
Q4 2021 | $285,548 | +8.0% | 6,475 | -6.4% | 0.23% | -1.3% |
Q3 2021 | $264,413 | -11.9% | 6,920 | -8.1% | 0.23% | -35.5% |
Q2 2021 | $300,000 | +11.5% | 7,530 | 0.0% | 0.36% | +45.2% |
Q1 2021 | $269,000 | +15.9% | 7,530 | +19.2% | 0.25% | +13.1% |
Q4 2020 | $232,000 | – | 6,315 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |